COR THERAPEUTICS, INC. APPOINTS WILLIAM F. BENNETT, PH.D., VICE PRESIDENT, RESEARCH.SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BUSINESS WIRE)--May 4, 1995--COR Therapeutics, Inc. (Nasdaq: CORR CORR Used on the consolidated tape to indicate a correction in a reported transaction : CORR.LAST.GY 50 WAS 51. ) today announced that William F. Bennett, Ph.D., has been appointed Vice President, Research. In this capacity, Dr. Bennett will be responsible for the Company's research activities and will report to Dr. Charles Homcy, Executive Vice President, Research and Development. Dr. David R. Phillips, a co-founder of COR who has served as Vice President, Research since the Company's inception, has become Principal Research Scientist at the Company. Prior to joining COR, Dr. Bennett, age 46, served as Staff Scientist and Director of Recovery Sciences at Genentech, Inc. Since joining Genentech in 1982, Dr. Bennett has held several research and managerial positions, including Staff Scientist, Department of Cardiovascular Research and t-PA research project team leader. Most recently, he was development project team leader for a second generation thrombolytic, Genentech's TNK-tPA compound. Previously, Dr. Bennett held positions as a research scientist at both the University of Texas Medical School and Rice University. In addition to his laboratory experience, Dr. Bennett has published and lectured extensively. He is currently a member of the American Society of Biochemistry and Molecular Biology and is an original member of the International Society of Fibrinolysis fibrinolysis /fi·bri·nol·y·sis/ (fi?brin-ol´i-sis) dissolution of fibrin by enzymatic action.fibrinolyt´ic fi·bri·nol·y·sis n. pl. and Thrombolysis. A native of Odessa, Texas, Dr. Bennett received his undergraduate degree from Texas Christian University Texas Christian University, at Fort Worth; Christian Church (Disciples of Christ); coeducational; opened 1873 at Thorp Spring, chartered 1874 as Add Ran Male and Female College. It assumed its present name in 1902 and moved to Fort Worth in 1910. and his doctorate degree in biochemistry from the University of Texas (Southwestern) Medical School. COR Therapeutics, Inc. is dedicated to the discovery, development and commercialization of novel pharmaceutical products for the treatment and prevention of severe cardiovascular diseases. COR has complementary product development programs that address critical needs in severe cardiovascular care, including unstable angina, acute myocardial infarction acute myocardial infarction (  ·kyōōtˑ mī·ō·karˑ·dē· , deep vein thrombosis A blood clot (thrombos) in a vein deep within the muscle, typically in the thigh or calf. It is caused by disease or the lack of activity such as sitting for hours at a computer screen. and restenosis. In addition to its recently announced collaboration with Schering-Plough Corporation, COR has established corporate collaborations with Eli Lilly and Company Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company and one of the world's largest corporations. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States. , Kyowa Hakko Kogyo Company, Ltd. and Ortho Pharmaceutical Corporation. CONTACT: COR Therapeutics, Inc. Laura A. Brege, 415/244-6893 or Burns McClellan, Inc. Lillian S. Stern, 212/505-1919 (Investors) Justin Jackson, 415/399-4525 (Media) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion